TDOC - Earnings announcements

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 ("First Quarter 2026"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2025 ("First Quarter 2025"). Highlights First Quarter 2026 revenue of $613.8 million, down 2% year-over-yearFirst Quarter 2026 net loss of $63.8 million, or $0.36 per shareFirst Quarter 2026 adjusted EBITDA of $58.2 million, essentially flat year-over-yearIntegrated Care segment revenue of $395.4 million, up 2% year-over-year, and adjusted EBITDA margin of 14.2%BetterHelp segmen

NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing (800) 715-9871 for U.S. participants and using the conference ID # 2214924. For international participants, please visit the following link for global dial-in numbers, using the same conference ID # 2214924: https://registrations.events/directory/international/itfs.html. A live audio webca

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 ("Fourth Quarter 2025") and full year ended December 31, 2025 ("Full Year 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 ("Fourth Quarter 2024") and full year ended December 31, 2024 ("Full Year 2024"). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat year-over-year, and Full Year 2025 revenue of $2,530.0 million, down 2% year-over-yearFourth Quarter 2025 net loss of $25.1 million, or $0.14 per share, and Full Year 2

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements of Eric Evans and Thomas McKinley and will serve on the board's audit and nominating and corporate governance committees. "Michael's experience leading enterprise transformations makes him a strong addition to the Board," sa

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=95347. A live audio webcast will also be available online at https:/

NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 ("Third Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 ("Third Quarter 2024"). Highlights Third Quarter 2025 revenue of $626.4 million, down 2% year-over-yearThird Quarter 2025 net loss of $49.5 million, or $0.28 per shareThird Quarter 2025 adjusted EBITDA of $69.9 million, down 16% year-over-yearIntegrated Care segment revenue of $389.5 million, up 2% year-over-year, and adjusted EBITDA margin of 17.0%BetterHelp seg

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial Officer to pursue an opportunity outside of the healthcare industry. Ms. Murthy will continue to serve in her role until her departure on November 21, 2025 and will present on the company's third quarter earnings conference call. The company has initiated a search process to identify its next CFO. To ensure a seamless transition while the search is completed, an interim leadership structure will be in place with key finance leaders reporting to Teladoc Health Chief Executive Officer Chuck Divita.

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.  Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 609817. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=90432. A live audio webcast will also be available online at ht

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024"). Highlights Second Quarter 2025 revenue of $631.9 million, down 2% year-over-yearSecond Quarter 2025 net loss of $32.7 million, or $0.19 per shareSecond Quarter 2025 adjusted EBITDA of $69.3 million, down 23% year-over-yearIntegrated Care segment revenue of $391.5 million, up 4% year-over-year, and adjusted EBITDA margin of 14.7%BetterHelp segment rev

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 606269. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=85796. A live audio webcast will also be available online at https://

PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu

PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 309585. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=81196. A live audio webcast will also be available online at h

PURCHASE, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 ("Full Year 2024") and three months ended December 31, 2024 ("Fourth Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 ("Full Year 2023") and three months ended December 31, 2023 ("Fourth Quarter 2023"). Full Year and Fourth Quarter 2024 Highlights Full Year 2024 revenue of $2,569.6 million, down 1% year-over-year, and Fourth Quarter 2024 revenue of $640.5 million, down 3% year-over-yearFull Year 2024 net loss of

PURCHASE, NY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release fourth quarter 2024 results on Wednesday, February 26, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. ET on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 259200. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=72270. A live audio webcast will also be available online at http

PURCHASE, NY, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended September 30, 2024 ("Third Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2023 ("Third Quarter 2023"). Third Quarter 2024 Highlights Third Quarter 2024 revenue of $640.5 million, down 3% year-over-yearThird Quarter 2024 net loss of $33.3 million, or $0.19 per shareThird Quarter 2024 adjusted EBITDA of $83.3 million, down 6% year-over-yearIntegrated Care segment revenue of $383.7 million, up 2% year-over-year, and adjusted EBIT

PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=72270. A live audio webcast will also be available o

PURCHASE, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended June 30, 2024 ("Second Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2023 ("Second Quarter 2023"). Financial and Operational Highlights for Second Quarter 2024 Second Quarter 2024 revenue of $642.4 million, down 2% year-over-yearSecond Quarter 2024 net loss of $837.7 million, or $4.92 per share, including a goodwill impairment charge of $790.0 million, or $4.64 per shareSecond Quarter 2024 adjusted EBITDA of $89.5 million, up 24%

PURCHASE, NY, July 17, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2024 results on Wednesday, July 31, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 453227. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=68682. A live audio webcast will also be avai

PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 ("First Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2023 ("First Quarter 2023"). Financial and Operational Highlights for First Quarter 2024 First Quarter 2024 revenue grows 3% year-over-year to $646.1 millionFirst Quarter 2024 net loss of $81.9 million, or $0.49 per shareFirst Quarter 2024 adjusted EBITDA of $63.1 million, up 20% year-over-year "We are pleased to report a solid start to the year, with strength

PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=60046. A live audio webcast will also be availa

Fourth quarter 2023 revenue increase of 4% and full year 2023 revenue increase of 8% to $2,602.4 millionFourth quarter 2023 net loss of $28.9 million, or $0.17 per share, and full year 2023 net loss of $220.4 million, or $1.34 per shareFourth quarter 2023 adjusted EBITDA increase of 22% to $114.4 million and full year 2023 adjusted EBITDA increase of 33% to $328.1 million, resulting in the company's most profitable year-to-dateFull year 2023 operating cash flow of $350.0 million, up from $189.3 million; full year 2023 free cash flow of $193.7 million, up from $16.5 million; cash position of $1,123.7 million as of December 31, 2023Initiates 2024 guidance, provides three year outlook PURCHASE

PURCHASE, NY, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its fourth quarter 2023 results, previously scheduled for 4:30 p.m. E.T. on February 20, 2024, will now start at 5:00 p.m. E.T. on that same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 825968. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=60046. A live audio webcast will also be available online at https://ir.

PURCHASE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release fourth quarter 2023 results on Tuesday, February 20, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 825968. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=60046. A live audio webcast will also be avai

Third quarter 2023 revenue grows 8% year-over-year to $660.2 millionThird quarter 2023 operating cash flow of $105.6 million; free cash flow of $68.0 millionThird quarter 2023 net loss of $57.1 million, or $0.35 per shareThird quarter 2023 adjusted EBITDA of $88.8 million, up 73% year-over-year PURCHASE, NY, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the third quarter ended September 30, 2023. "Our third quarter financial and operating performance reinforces the fundamental strength of our business and our success in making better health available to more than 90 million mem

PURCHASE, NY, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2023 results on Tuesday, October 24, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 612441. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=55509. A live audio webcast will also be available on

Second quarter 2023 revenue grows 10% year-over-year to $652.4 millionSecond quarter 2023 operating cash flow of $101.2 million; free cash flow of $64.6 millionSecond quarter 2023 net loss of $65.2 million, or $0.40 per shareSecond quarter 2023 adjusted EBITDA of $72.2 million PURCHASE, NY, July 25, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the second quarter ended June 30, 2023. "Teladoc Health continues to set the standard for delivery of innovative, whole person virtual healthcare solutions to an ever-demanding marketplace focused on the intersection of quality and cost of care," sai

PURCHASE, NY, July 10, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2023 results on Tuesday, July 25, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 447516. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=51877. A live audio webcast will also be available onli

First quarter 2023 revenue grows 11% year-over-year to $629.2 million First quarter 2023 net loss of $69.2 million, or $0.42 per shareFirst quarter adjusted EBITDA totaled $52.8 million PURCHASE, NY, April 26, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the first quarter ended March 31, 2023.   "Teladoc Health delivered strong first quarter results across all key financial and operating metrics to start the year," said Jason Gorevic, chief executive officer of Teladoc Health. "With a strong financial position, we are able to fund and invest in innovations and a world-class team of medical

PURCHASE, NY, April 12, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2023 results on Wednesday, April 26, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 517662. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=48865. A live audio webcast will also be available o

Fourth quarter revenue grows 15% year-over-year to $637.7 million and full year revenue grows 18% year-over-year to $2,406.8 million 2022 full year cash flow from operating activities and free cash flow was $189.3 million and $16.5 million, respectively; Cash position of $918.2 million as of December 31, 2022 Fourth quarter net loss per share of $23.49 and full year net loss per share of $84.60, driven by non-cash goodwill impairment charges of $23.26 per share in fourth quarter and $83.01 per share for full year Fourth quarter adjusted EBITDA totaled $94.1 million and full year adjusted EBITDA totaled $246.5 million Disclosures expanded to include Teladoc Health Integrated Care segment

PURCHASE, NY, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release fourth quarter 2022 results on Wednesday, February 22, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and using the access code # 033061; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/. A replay of t

Third quarter revenue grows 17% year-over-year to $611.4 millionNet loss totaled $73.5 million, or $0.45 per shareAdjusted EBITDA totaled $51.2 millionCash flow from operating activities was $63.0 million for the quarter and $123.7 million year-to-date PURCHASE, NY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the third quarter ended September 30, 2022. "Teladoc Health delivered strong third quarter results, including robust revenue growth, and adjusted EBITDA above the high end of expectations," said Jason Gorevic, chief executive officer of Teladoc Health. "During the quarter we

PURCHASE, NY, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2022 results on Wednesday, October 26, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and using the access code # 270257; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/. A replay of the

Second quarter revenue grows 18% year-over-year to $592.4 million. Net loss per share of $19.22, primarily driven by non-cash goodwill impairment charge of $3.0 billion, or $18.78 per share.Primary360 adds multiple new clients, and new capabilities, as early momentum continues PURCHASE, NY, July 27, 2022 (GLOBE NEWSWIRE) --  Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the second quarter ended June 30, 2022.   "Teladoc Health delivered solid second quarter results with significant progress against our whole person care strategy, including growing momentum in Primary360", said Jason Gorevic, chief executive officer

PURCHASE, NY, July 12, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release second quarter 2022 results on Wednesday, July 27, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and using the access code # 303657; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/. A replay of the

First quarter revenue grows 25% year-over-year to $565.4 million Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6 billion or $41.11 per shareFull year guidance ranges for 2022 revenue, net loss per share and adjusted EBITDA revised to $2.4 - $2.5 billion, ($43.50) per share - ($43.00) per share, and $240 - $265 million, respectively PURCHASE, NY, April 27, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the first quarter ended March 31, 2022.   "Teladoc Health continues to be the global leader in transforming healthcare, delivering personalized, fl

PURCHASE, NY, April 06, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2022 results on Wednesday, April 27, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and referencing conference ID #843324; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/. A replay

Fourth quarter revenue grows 45% year-over-year to $554.2 million and total visits increase 41% to 4.4 million Full year revenue grows 86% year-over-year to $2,032.7 million and total visits increase 38% to 15.4 millionFull year cash flows from operations grew to $194.0 millionFull year 2022 Revenue guidance of $2.55 to $2.65 billion, representing 25% to 30% growth PURCHASE, NY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the fourth quarter and full year ended December 31, 2021.   "Teladoc Health took a huge step forward in bringing true whole-person care to life for consumers an

PURCHASE, NY, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release fourth quarter and full year 2021 results on Tuesday, February 22, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-844-200-6205 for U.S. participants, or 1-929-526-1599 for international participants, and referencing conference ID #335463; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/.

NEW YORK, Nov. 16, 2021 /PRNewswire/ -- Telehealth seems to be going strong with no signs of slowing down in the post-pandemic era. As telehealth companies develop programs to support online care, insurance companies like Humana have developed affordable healthcare plans for those seeking online healthcare. In addition to supporting telehealth, these companies are seeing an increase in the adoption of digital healthcare and cost savings associated with the same. Meanwhile, telehealth companies such as CloudMD Software & Services Inc. (TSXV:DOC) (OTCPK: DOCRF), Veeva Systems, Inc. (NYSE:VEEV), 1LifeHealthcare, Inc. (NASDAQ: ONEM), Teladoc Health (NYSE:TDOC), and Allscripts Healthcare Solution

Third quarter revenue grows 81% year-over-year to $522 million, updating 2021 revenue outlook to $2,015 million to $2,025 million. Total third quarter visits top 3.9 million – 37% higher than Q3 2020.Significant new agreements with CVS Health and Centene to provide Teladoc Health's Primary360 to deliver greater care access and health engagement.Teladoc Health ranked 1st in consumer satisfaction by J.D. Power 2021 U.S. Telehealth Satisfaction Study. PURCHASE, NY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the quarter ended September 30, 2021.   "Our strong performance in the

PURCHASE, NY, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, announced that it will release third-quarter 2021 results on Wednesday, October 27th, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-968-2101 for U.S. participants, or 1-236-714-2089 for international participants, and referencing conference ID #3489052; or via a live audio webcast that will be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/. A replay

Second quarter revenue grows 109% year-over-year to $503 million, driving 2021 revenue outlook increase to $2,000 million to $2,025 million. Total second quarter visits top 3.5 million – 28% higher than Q2 2020, in the first wave of the pandemic.Significant new agreement with HCSC to provide Teladoc Health's suite of whole-person chronic care solutions.Launched myStrength Complete, an integrated mental health service that combines app-based tools and coaching expertise with Teladoc's therapists and psychiatrists to enable consumers to receive the level of mental health support and care they need, when they need it. PURCHASE, NY, July 27, 2021 (GLOBE NEWSWIRE) --  Teladoc Health, Inc. (N

PALM BEACH,  Fla., Dec. 1, 2020 /PRNewswire/ -- In times of turmoil many small companies struggle to survive and this pandemic has launched M&A across many industries… healthcare is one of them. Sometimes small companies initially may try to maintain their independence but, eventually they see that maybe the best thing for their patients is to become part of a larger whole. Providers have been consolidating over the last decade as organizations pursue economies of scale and expand vertically and horizontally. Post–Covid-19, it is expected that larger healthcare groups and investors will accelerate their acquisitions of smaller hospitals, physician practices and alternative sites of care.